ORIGINAL ARTICLE: A Phase 2 Trial of Surgery With Perioperative INGN 201 (Ad5CMV-p53) Gene Therapy Followed by Chemoradiotherapy for Advanced, Resectable Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx, and Larynx: Report of the Southwest Oncology Group

G. H Yoo, J Moon, M LeBlanc, F Lonardo, S Urba, H Kim, E Hanna, T Tsue, J Valentino, J Ensley and G. Wolf

Archives of Otolaryngology - Head and Neck Surgery 135 ( 9 ): 869 - 874 , 2009